956958-53-5
956958-53-5
Chemical Structure
Pilaralisib analogue
Synonym(s): XL147 analogue
- CAS No.: 956958-53-5
- Formula:C21H16N6O2S2
- Molecular Weight:448.52
IUPAC Name: N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
InChIKey: MQMKRQLTIWPEDM-UHFFFAOYSA-N
SMILES: O=S(C1=CC=C(C)C=C1)(NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4)=O
Biological Activity: Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pilaralisib analogue | 99.74% | Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pilaralisib analogue (Standard) | ≥98% | Pilaralisib analogue (Standard) is the analytical standard of Pilaralisib analogue (HY-11105). This product is intended for research and analytical applications. Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
